h i g h l i g h t s
Axonal degeneration is an integral part of the disease process in MMN. Axonal loss in MMN may be masked by prominent re-innervation. Nerve conduction studies are not sensitive to motor unit remodelling in MMN.
a b s t r a c t
Objective: To estimate the degree of axonal loss in patients diagnosed with multifocal motor neuropathy (MMN) using a novel assessment of motor unit numbers and size. Methods: Automated motor unit number estimation using a compound muscle action potential (CMAP) scan was undertaken in median nerves with conduction block. Results were compared with 30 age-matched healthy controls. Results: Compared with healthy controls, MMN patients had fewer motor units (MMN: 33 ± 11 vs HC: 93 ± 36 [mean ± SD]; p < 0.0001) and larger 'size of the largest unit' (MMN: 1.2 ± 0.5 mV vs HC: 0.4 ± 0.1 mV; p < 0.0001), despite having normal distal CMAP amplitudes (MMN: 7.6 ± 1.8 mV vs HC: 8.7 ± 2.5 mV; p = 0.24). Conclusions: MMN is associated with marked axonal loss which may be masked by striking re-innervation resulting in preservation of distal CMAP amplitudes. Significance: Assessment of motor unit properties should be incorporated into assessment of disease progression in MMN, given that nerve conduction studies are insensitive to motor unit remodelling.
Crown Copyright Ó 2017 Published by Elsevier Ireland Ltd on behalf of International Federation of Clinical Neurophysiology. All rights reserved.
Introduction
Progressive axonal degeneration is a prominent feature of multifocal motor neuropathy (MMN), differentiating it from the other immune-mediated neuropathies (Vlam et al., 2011) . The aim of immunomodulatory treatment with intravenous immunoglobulin (IVIg) has been to reduce the rate of axonal loss as this is the most important determinant of permanent weakness and disability (Van Asseldonk et al., 2006; Vucic et al., 2004 
